EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Capsanthin at the crossroads of arthritis: from molecular mechanisms to therapeutic avenues

Injamul Islam, Piyali Dey iD

Inflammopharmacology · 29.10.2026

DOI: 10.1007/s10787-026-02437-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 29.10.2026. Verfasst von Injamul Islam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Science, Assam down town University, Gandhi Nagar, Sankar Madhab Path, Panikhaiti, Guwahati, Assam, 781026, India. Die Arbeit nennt 113 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arthritis, particularly rheumatoid arthritis (RA) and osteoarthritis (OA), is a multifactorial musculoskeletal disorder characterized by chronic inflammation, oxidative stress, immune dysregulation, mitochondrial dysfunction, extracellular matrix degradation and progressive cartilage and bone destruction. Although conventional therapies, including disease-modifying antirheumatic drugs, biologics and JAK inhibitors, have improved disease management, their long-term use is frequently associated with adverse effects, therapeutic resistance and incomplete prevention of irreversible joint degeneration, necessitating safer multitarget therapeutic strategies. Capsicum species contain diverse bioactive constituents, including capsanthin, capsorubin, capsaicin, dihydrocapsaicin, β-carotene and zeaxanthin. Among these, capsanthin, found in Capsicum species, has attracted considerable interest because of its potent antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulatory properties. This review comprehensively evaluates the potential anti-arthritic activity of capsanthin, with particular emphasis on signaling networks implicated in joint inflammation, oxidative stress, immune dysregulation, and extracellular matrix degradation, including CB2, NF- κ B, Nrf2/HO-1, MAPK, PI3K/Akt, and JAK/STAT pathways. The available evidence is critically distinguished according to capsanthin-specific findings, arthritis-related mechanisms, and supportive evidence from other carotenoids or disease models. Additionally, modulation of matrix metalloproteinases (MMPs) and ADAMTS aggrecanases involved in cartilage degradation and extracellular matrix remodeling is critically discussed. Current preclinical evidence indicates that capsanthin suppresses pro-inflammatory cytokine production, restores cellular redox homeostasis, attenuates oxidative stress-mediated signaling, and preserves cartilage integrity through coordinated regulation of interconnected molecular networks. Emerging computational approaches, including network pharmacology, molecular docking, molecular dynamics simulations, artificial intelligence-assisted drug discovery, and multi-omics technologies, are also highlighted to accelerate target identification, mechanism and future clinical translation. Graphical abstract Capsanthin, a carotenoid from Capsicum species, shows strong therapeutic potential against Rheumatoid Arthritis (RA) and Osteoarthritis (OA). It targets multiple molecular pathways-inhibiting NF-kB, JAK/STAT, MAPK, and MMPs/ADAMTS while activating Nrf2/HO-1, PI3K/Akt, and CB2 receptors. These actions reduce inflammation and oxidative stress, modulate immune responses, protect cartilage and extracellular matrix structure. Ultimately, this leads to decreased pain, stiffness, cartilage degradation, and bone erosion, thereby improving overall joint function. Its development is further supported by network pharmacology, molecular docking, AI, multi-omics and preclinical-to-clinical translational research.

Schlagwörter

Stichwörter der Autor:innen

ArthritisCapsanthinExperimental interventionMolecular signaling pathwayPathogenesis mechanism

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Science, Assam down town University, Gandhi Nagar, Sankar Madhab Path, Panikhaiti, Guwahati, Assam, 781026, India.
  • Faculty of Pharmaceutical Science, Assam down town University, Gandhi Nagar, Sankar Madhab Path, Panikhaiti, Guwahati, Assam, 781026, India. piyali.drl@gmail.com.

ORCID-Profile: Piyali Dey

Zitieren

APA

Islam, I., & Dey, P. (2026). Capsanthin at the crossroads of arthritis: from molecular mechanisms to therapeutic avenues. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02437-6

Vancouver

Islam I, Dey P. Capsanthin at the crossroads of arthritis: from molecular mechanisms to therapeutic avenues. Inflammopharmacology. 2026. doi:10.1007/s10787-026-02437-6

BibTeX
@article{Islam2026,
  author = {Islam, Injamul and Dey, Piyali},
  title = {Capsanthin at the crossroads of arthritis: from molecular mechanisms to therapeutic avenues},
  journal = {Inflammopharmacology},
  year = {2026},
  doi = {10.1007/s10787-026-02437-6}
}
Kostenlos starten →